×
For best experience we recommend to activate Javascript in your browser.
DRAK2 antibody (AA 272-372)
The Mouse Monoclonal anti-DRAK2 antibody (Clone 2C3) (ABIN564000) specifically detects DRAK2 in ELISA, WB, IHC (p) and IF.
The antibody is reactive with Human samples.
Catalog No. ABIN564000
$520.15
Plus shipping costs $50.00
Delivery in 11 to 14 Business Days
Quick Overview for DRAK2 antibody (AA 272-372) (ABIN564000)
Target
See all DRAK2 (STK17B) Antibodies
DRAK2 (STK17B)
(serine/threonine Kinase 17b (STK17B))
Reactivity
All reactivities for DRAK2 antibodies
Human
Host
All hosts for DRAK2 antibodies
Mouse
Clonality
All clonalities for DRAK2 antibodies
Monoclonal
Conjugate
All conjugates for DRAK2 antibodies
This DRAK2 antibody is un-conjugated
Application
All applications for DRAK2 antibodies
ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)
Clone
2C3
Product Details anti-DRAK2 Antibody
(hide)
Binding Specificity
All epitopes for DRAK2 antibodies
AA 272-372
Purpose
Mouse monoclonal antibody raised against a partial recombinant STK17B.
Sequence
SLLVKNPEKR PTAEICLSHS WLQQWDFENL FHPEETSSSS QTQDHSVRSS EDKTSKSSCN GTCGDREDKE NIPEDSSMVS KRFRFDDSLP NPHELVSDLL C
Cross-Reactivity
Human
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
STK17B (AAH16040, 272 a.a. ~ 372 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Isotype
IgG2b
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Buffer
In 1x PBS, pH 7.4
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Target Details for DRAK2
(hide)
Target
DRAK2 (STK17B)
(serine/threonine Kinase 17b (STK17B))
Alternative Name
STK17B
Background
Full Gene Name: serine/threonine kinase 17b Synonyms: DRAK2
Gene ID
9262
Recently viewed
(hide)
Chat with us , powered by LiveChat